These assays examine the ability of BRCA1 and BRCA2 variants to support cell viability, sensitivity to DNA damaging agents, ability to repair DSBs by HR, or to exhibit transcriptional activity and predict the role of mutations in cancer-predisposition [16–25]. Here, BRCA2 is linked to cancer.